Company Filing History:
Years Active: 2001-2002
Title: Andrew John Hammond Smith: Innovator in Specific Binding Pairs
Introduction
Andrew John Hammond Smith is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing members of specific binding pairs. With a total of 3 patents to his name, his work has the potential to impact various applications in medical and research settings.
Latest Patents
Smith's latest patents focus on innovative methods for producing members of specific binding pairs (sbp). One of his inventions discloses methods, recombinant host cells, and kits for the production of sbp members, such as antibodies. This process utilizes display on the surface of secreted replicable genetic display packages (rgdps), like filamentous phage. The invention emphasizes the importance of creating a library of great diversity through recombination between first and second vectors that encode the polypeptide chains of sbp members. This recombination can occur either in vitro or intracellularly and may involve site-specific techniques, such as the use of the loxP sequence. Additionally, the methods enable the production of libraries of multimeric sbp members from a vast array of possible combinations, enhancing the specificity for counterpart sbp members.
Career Highlights
Throughout his career, Andrew John Hammond Smith has focused on advancing the field of biotechnology. His innovative approaches to producing specific binding pairs have garnered attention and recognition within the scientific community. His work not only contributes to the understanding of protein interactions but also paves the way for new therapeutic developments.
Collaborations
Smith has collaborated with esteemed colleagues, including Gregory Paul Winter and Kevin Stuart Johnson. These partnerships have further enriched his research and have led to significant advancements in the field.
Conclusion
Andrew John Hammond Smith is a prominent inventor whose work in producing specific binding pairs has the potential to revolutionize biotechnology. His innovative methods and collaborative efforts continue to drive progress in this important area of research.